▶ 調査レポート

臨床バイオマーカーの世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Clinical Biomarkers Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。臨床バイオマーカーの世界市場2020年:企業別、地域別、種類・用途別 / Global Clinical Biomarkers Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-00908資料のイメージです。• レポートコード:D0GIR-00908
• 出版社/出版日:GlobalInfoResearch / 2020年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、臨床バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。臨床バイオマーカーの種類別市場規模(診断バイオマーカー、予測バイオマーカー、予後バイオマーカー)、用途別市場規模(研究・学術研究所、バイオ医薬品・バイオテクノロジー企業、診断センター、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Abbott Laboratories、F. Hoffmann-La Roche Ltd.、Becton, Dickinson and Company、Agilent Technologies, Inc.、CENTOGENE N.V.、ALCEDIAG、Illumina, Inc.、Bio-Rad Laboratories, Inc.、bioMérieux S.A.、Enzo Biochem Inc.、Myriad Genetics, Inc.、Thermo Fisher Scientific Inc.、Quest Diagnostics Incorporated、QIAGEN N.V.
・地域別グローバル市場分析 2015年-2020年
・臨床バイオマーカーの北米市場(アメリカ、カナダ、メキシコ)
・臨床バイオマーカーのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・臨床バイオマーカーのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・臨床バイオマーカーの南米市場(ブラジル、アルゼンチン)
・臨床バイオマーカーの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:診断バイオマーカー、予測バイオマーカー、予後バイオマーカー
・用途別分析:研究・学術研究所、バイオ医薬品・バイオテクノロジー企業、診断センター、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Clinical Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Clinical Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Clinical Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Clinical Biomarkers market has been segmented into:
Diagnostic Biomarkers
Predictive Biomarkers
Prognostic Biomarkers

By Application, Clinical Biomarkers has been segmented into:
Research and Academic Laboratories
Biopharmaceutical and Biotech Companies
Diagnostic Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Clinical Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Clinical Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Clinical Biomarkers market.

The report offers in-depth assessment of the growth and other aspects of the Clinical Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Clinical Biomarkers Market Share Analysis
Clinical Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Clinical Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Clinical Biomarkers sales, revenue and market share for each player covered in this report.

The major players covered in Clinical Biomarkers are:
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Agilent Technologies, Inc.
CENTOGENE N.V.
ALCEDIAG
Illumina, Inc.
Bio-Rad Laboratories, Inc.
bioMérieux S.A.
Enzo Biochem Inc.
Myriad Genetics, Inc.
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
QIAGEN N.V.
Among other players domestic and global, Clinical Biomarkers market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Clinical Biomarkers Market Overview
1.1 Product Overview and Scope of Clinical Biomarkers
1.2 Classification of Clinical Biomarkers by Type
1.2.1 Global Clinical Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Clinical Biomarkers Revenue Market Share by Type in 2019
1.2.3 Diagnostic Biomarkers
1.2.4 Predictive Biomarkers
1.2.5 Prognostic Biomarkers
1.3 Global Clinical Biomarkers Market by Application
1.3.1 Overview: Global Clinical Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research and Academic Laboratories
1.3.3 Biopharmaceutical and Biotech Companies
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Global Clinical Biomarkers Market by Regions
1.4.1 Global Clinical Biomarkers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Clinical Biomarkers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Clinical Biomarkers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Clinical Biomarkers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Biomarkers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Clinical Biomarkers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Biomarkers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.2 F. Hoffmann-La Roche Ltd.
2.2.1 F. Hoffmann-La Roche Ltd. Details
2.2.2 F. Hoffmann-La Roche Ltd. Major Business
2.2.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.2.4 F. Hoffmann-La Roche Ltd. Product and Services
2.2.5 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.3 Becton, Dickinson and Company
2.3.1 Becton, Dickinson and Company Details
2.3.2 Becton, Dickinson and Company Major Business
2.3.3 Becton, Dickinson and Company SWOT Analysis
2.3.4 Becton, Dickinson and Company Product and Services
2.3.5 Becton, Dickinson and Company Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agilent Technologies, Inc.
2.4.1 Agilent Technologies, Inc. Details
2.4.2 Agilent Technologies, Inc. Major Business
2.4.3 Agilent Technologies, Inc. SWOT Analysis
2.4.4 Agilent Technologies, Inc. Product and Services
2.4.5 Agilent Technologies, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.5 CENTOGENE N.V.
2.5.1 CENTOGENE N.V. Details
2.5.2 CENTOGENE N.V. Major Business
2.5.3 CENTOGENE N.V. SWOT Analysis
2.5.4 CENTOGENE N.V. Product and Services
2.5.5 CENTOGENE N.V. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.6 ALCEDIAG
2.6.1 ALCEDIAG Details
2.6.2 ALCEDIAG Major Business
2.6.3 ALCEDIAG Product and Services
2.6.4 ALCEDIAG Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.7 Illumina, Inc.
2.7.1 Illumina, Inc. Details
2.7.2 Illumina, Inc. Major Business
2.7.3 Illumina, Inc. Product and Services
2.7.4 Illumina, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio-Rad Laboratories, Inc.
2.8.1 Bio-Rad Laboratories, Inc. Details
2.8.2 Bio-Rad Laboratories, Inc. Major Business
2.8.3 Bio-Rad Laboratories, Inc. Product and Services
2.8.4 Bio-Rad Laboratories, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.9 bioMérieux S.A.
2.9.1 bioMérieux S.A. Details
2.9.2 bioMérieux S.A. Major Business
2.9.3 bioMérieux S.A. Product and Services
2.9.4 bioMérieux S.A. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.10 Enzo Biochem Inc.
2.10.1 Enzo Biochem Inc. Details
2.10.2 Enzo Biochem Inc. Major Business
2.10.3 Enzo Biochem Inc. Product and Services
2.10.4 Enzo Biochem Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.11 Myriad Genetics, Inc.
2.11.1 Myriad Genetics, Inc. Details
2.11.2 Myriad Genetics, Inc. Major Business
2.11.3 Myriad Genetics, Inc. Product and Services
2.11.4 Myriad Genetics, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.12 Thermo Fisher Scientific Inc.
2.12.1 Thermo Fisher Scientific Inc. Details
2.12.2 Thermo Fisher Scientific Inc. Major Business
2.12.3 Thermo Fisher Scientific Inc. Product and Services
2.12.4 Thermo Fisher Scientific Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.13 Quest Diagnostics Incorporated
2.13.1 Quest Diagnostics Incorporated Details
2.13.2 Quest Diagnostics Incorporated Major Business
2.13.3 Quest Diagnostics Incorporated Product and Services
2.13.4 Quest Diagnostics Incorporated Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.14 QIAGEN N.V.
2.14.1 QIAGEN N.V. Details
2.14.2 QIAGEN N.V. Major Business
2.14.3 QIAGEN N.V. Product and Services
2.14.4 QIAGEN N.V. Clinical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Clinical Biomarkers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Clinical Biomarkers Players Market Share
3.2.2 Top 10 Clinical Biomarkers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Clinical Biomarkers Revenue and Market Share by Regions
4.2 North America Clinical Biomarkers Revenue and Growth Rate (2015-2020)
4.3 Europe Clinical Biomarkers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Clinical Biomarkers Revenue and Growth Rate (2015-2020)
4.5 South America Clinical Biomarkers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Clinical Biomarkers Revenue and Growth Rate (2015-2020)
5 North America Clinical Biomarkers Revenue by Countries
5.1 North America Clinical Biomarkers Revenue by Countries (2015-2020)
5.2 USA Clinical Biomarkers Revenue and Growth Rate (2015-2020)
5.3 Canada Clinical Biomarkers Revenue and Growth Rate (2015-2020)
5.4 Mexico Clinical Biomarkers Revenue and Growth Rate (2015-2020)
6 Europe Clinical Biomarkers Revenue by Countries
6.1 Europe Clinical Biomarkers Revenue by Countries (2015-2020)
6.2 Germany Clinical Biomarkers Revenue and Growth Rate (2015-2020)
6.3 UK Clinical Biomarkers Revenue and Growth Rate (2015-2020)
6.4 France Clinical Biomarkers Revenue and Growth Rate (2015-2020)
6.5 Russia Clinical Biomarkers Revenue and Growth Rate (2015-2020)
6.6 Italy Clinical Biomarkers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Clinical Biomarkers Revenue by Countries
7.1 Asia-Pacific Clinical Biomarkers Revenue by Countries (2015-2020)
7.2 China Clinical Biomarkers Revenue and Growth Rate (2015-2020)
7.3 Japan Clinical Biomarkers Revenue and Growth Rate (2015-2020)
7.4 Korea Clinical Biomarkers Revenue and Growth Rate (2015-2020)
7.5 India Clinical Biomarkers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Clinical Biomarkers Revenue and Growth Rate (2015-2020)
8 South America Clinical Biomarkers Revenue by Countries
8.1 South America Clinical Biomarkers Revenue by Countries (2015-2020)
8.2 Brazil Clinical Biomarkers Revenue and Growth Rate (2015-2020)
8.3 Argentina Clinical Biomarkers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Clinical Biomarkers by Countries
9.1 Middle East & Africa Clinical Biomarkers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Clinical Biomarkers Revenue and Growth Rate (2015-2020)
9.3 UAE Clinical Biomarkers Revenue and Growth Rate (2015-2020)
9.4 Egypt Clinical Biomarkers Revenue and Growth Rate (2015-2020)
9.5 South Africa Clinical Biomarkers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Clinical Biomarkers Revenue and Market Share by Type (2015-2020)
10.2 Global Clinical Biomarkers Market Forecast by Type (2019-2024)
10.3 Diagnostic Biomarkers Revenue Growth Rate (2015-2025)
10.4 Predictive Biomarkers Revenue Growth Rate (2015-2025)
10.5 Prognostic Biomarkers Revenue Growth Rate (2015-2025)
11 Global Clinical Biomarkers Market Segment by Application
11.1 Global Clinical Biomarkers Revenue Market Share by Application (2015-2020)
11.2 Clinical Biomarkers Market Forecast by Application (2019-2024)
11.3 Research and Academic Laboratories Revenue Growth (2015-2020)
11.4 Biopharmaceutical and Biotech Companies Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Clinical Biomarkers Market Size Forecast (2021-2025)
12.1 Global Clinical Biomarkers Market Size Forecast (2021-2025)
12.2 Global Clinical Biomarkers Market Forecast by Regions (2021-2025)
12.3 North America Clinical Biomarkers Revenue Market Forecast (2021-2025)
12.4 Europe Clinical Biomarkers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Clinical Biomarkers Revenue Market Forecast (2021-2025)
12.6 South America Clinical Biomarkers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Clinical Biomarkers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Clinical Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Clinical Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Clinical Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Clinical Biomarkers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Clinical Biomarkers Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbott Laboratories Corporate Information, Location and Competitors
Table 7. Abbott Laboratories Clinical Biomarkers Major Business
Table 8. Abbott Laboratories Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 9. Abbott Laboratories SWOT Analysis
Table 10. Abbott Laboratories Clinical Biomarkers Product and Solutions
Table 11. Abbott Laboratories Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. F. Hoffmann-La Roche Ltd. Corporate Information, Location and Competitors
Table 13. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Major Business
Table 14. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Total Revenue (USD Million) (2018-2019)
Table 15. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 16. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Product and Solutions
Table 17. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Becton, Dickinson and Company Corporate Information, Location and Competitors
Table 19. Becton, Dickinson and Company Clinical Biomarkers Major Business
Table 20. Becton, Dickinson and Company Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 21. Becton, Dickinson and Company SWOT Analysis
Table 22. Becton, Dickinson and Company Clinical Biomarkers Product and Solutions
Table 23. Becton, Dickinson and Company Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Agilent Technologies, Inc. Corporate Information, Location and Competitors
Table 25. Agilent Technologies, Inc. Clinical Biomarkers Major Business
Table 26. Agilent Technologies, Inc. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 27. Agilent Technologies, Inc. SWOT Analysis
Table 28. Agilent Technologies, Inc. Clinical Biomarkers Product and Solutions
Table 29. Agilent Technologies, Inc. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. CENTOGENE N.V. Corporate Information, Location and Competitors
Table 31. CENTOGENE N.V. Clinical Biomarkers Major Business
Table 32. CENTOGENE N.V. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 33. CENTOGENE N.V. SWOT Analysis
Table 34. CENTOGENE N.V. Clinical Biomarkers Product and Solutions
Table 35. CENTOGENE N.V. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. ALCEDIAG Corporate Information, Location and Competitors
Table 37. ALCEDIAG Clinical Biomarkers Major Business
Table 38. ALCEDIAG Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 39. ALCEDIAG SWOT Analysis
Table 40. ALCEDIAG Clinical Biomarkers Product and Solutions
Table 41. ALCEDIAG Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Illumina, Inc. Corporate Information, Location and Competitors
Table 43. Illumina, Inc. Clinical Biomarkers Major Business
Table 44. Illumina, Inc. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 45. Illumina, Inc. SWOT Analysis
Table 46. Illumina, Inc. Clinical Biomarkers Product and Solutions
Table 47. Illumina, Inc. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 49. Bio-Rad Laboratories, Inc. Clinical Biomarkers Major Business
Table 50. Bio-Rad Laboratories, Inc. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 51. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 52. Bio-Rad Laboratories, Inc. Clinical Biomarkers Product and Solutions
Table 53. Bio-Rad Laboratories, Inc. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. bioMérieux S.A. Corporate Information, Location and Competitors
Table 55. bioMérieux S.A. Clinical Biomarkers Major Business
Table 56. bioMérieux S.A. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 57. bioMérieux S.A. SWOT Analysis
Table 58. bioMérieux S.A. Clinical Biomarkers Product and Solutions
Table 59. bioMérieux S.A. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Enzo Biochem Inc. Corporate Information, Location and Competitors
Table 61. Enzo Biochem Inc. Clinical Biomarkers Major Business
Table 62. Enzo Biochem Inc. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 63. Enzo Biochem Inc. SWOT Analysis
Table 64. Enzo Biochem Inc. Clinical Biomarkers Product and Solutions
Table 65. Enzo Biochem Inc. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Myriad Genetics, Inc. Corporate Information, Location and Competitors
Table 67. Myriad Genetics, Inc. Clinical Biomarkers Major Business
Table 68. Myriad Genetics, Inc. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 69. Myriad Genetics, Inc. SWOT Analysis
Table 70. Myriad Genetics, Inc. Clinical Biomarkers Product and Solutions
Table 71. Myriad Genetics, Inc. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Thermo Fisher Scientific Inc. Corporate Information, Location and Competitors
Table 73. Thermo Fisher Scientific Inc. Clinical Biomarkers Major Business
Table 74. Thermo Fisher Scientific Inc. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 75. Thermo Fisher Scientific Inc. SWOT Analysis
Table 76. Thermo Fisher Scientific Inc. Clinical Biomarkers Product and Solutions
Table 77. Thermo Fisher Scientific Inc. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Quest Diagnostics Incorporated Corporate Information, Location and Competitors
Table 79. Quest Diagnostics Incorporated Clinical Biomarkers Major Business
Table 80. Quest Diagnostics Incorporated Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 81. Quest Diagnostics Incorporated SWOT Analysis
Table 82. Quest Diagnostics Incorporated Clinical Biomarkers Product and Solutions
Table 83. Quest Diagnostics Incorporated Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. QIAGEN N.V. Corporate Information, Location and Competitors
Table 85. QIAGEN N.V. Clinical Biomarkers Major Business
Table 86. QIAGEN N.V. Clinical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 87. QIAGEN N.V. SWOT Analysis
Table 88. QIAGEN N.V. Clinical Biomarkers Product and Solutions
Table 89. QIAGEN N.V. Clinical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Global Clinical Biomarkers Revenue (Million USD) by Players (2015-2020)
Table 91. Global Clinical Biomarkers Revenue Share by Players (2015-2020)
Table 92. Global Clinical Biomarkers Revenue (Million USD) by Regions (2015-2020)
Table 93. Global Clinical Biomarkers Revenue Market Share by Regions (2015-2020)
Table 94. North America Clinical Biomarkers Revenue by Countries (2015-2020)
Table 95. North America Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Table 96. Europe Clinical Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 97. Asia-Pacific Clinical Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 98. South America Clinical Biomarkers Revenue by Countries (2015-2020)
Table 99. South America Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Table 100. Middle East and Africa Clinical Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 101. Middle East and Africa Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Table 102. Global Clinical Biomarkers Revenue (Million USD) by Type (2015-2020)
Table 103. Global Clinical Biomarkers Revenue Share by Type (2015-2020)
Table 104. Global Clinical Biomarkers Revenue Forecast by Type (2021-2025)
Table 105. Global Clinical Biomarkers Revenue by Application (2015-2020)
Table 106. Global Clinical Biomarkers Revenue Share by Application (2015-2020)
Table 107. Global Clinical Biomarkers Revenue Forecast by Application (2021-2025)
Table 108. Global Clinical Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Clinical Biomarkers Picture
Figure 2. Global Clinical Biomarkers Revenue Market Share by Type in 2019
Figure 3. Diagnostic Biomarkers Picture
Figure 4. Predictive Biomarkers Picture
Figure 5. Prognostic Biomarkers Picture
Figure 6. Clinical Biomarkers Revenue Market Share by Application in 2019
Figure 7. Research and Academic Laboratories Picture
Figure 8. Biopharmaceutical and Biotech Companies Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Others Picture
Figure 11. Global Clinical Biomarkers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Clinical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Clinical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Clinical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Clinical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Clinical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Clinical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Clinical Biomarkers Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Clinical Biomarkers Revenue Market Share in 2019
Figure 20. Global Top 10 Players Clinical Biomarkers Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Clinical Biomarkers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Clinical Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 24. Global Clinical Biomarkers Revenue Market Share by Regions in 2018
Figure 25. North America Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 26. Europe Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 28. South America Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 30. North America Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 31. North America Clinical Biomarkers Revenue Market Share by Countries in 2019
Figure 32. USA Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 33. Canada Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 35. Europe Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Clinical Biomarkers Revenue Market Share by Countries in 2019
Figure 37. Germany Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 38. UK Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 39. France Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 40. Russia Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 41. Italy Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Clinical Biomarkers Revenue Market Share by Countries in 2019
Figure 44. China Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 45. Japan Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 46. Korea Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 47. India Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 49. South America Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 50. South America Clinical Biomarkers Revenue Market Share by Countries in 2019
Figure 51. Brazil Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Clinical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Clinical Biomarkers Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 56. UAE Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Clinical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 59. Global Clinical Biomarkers Revenue Share by Type (2015-2020)
Figure 60. Global Clinical Biomarkers Revenue Share by Type in 2019
Figure 61. Global Clinical Biomarkers Market Share Forecast by Type (2021-2025)
Figure 62. Global Diagnostic Biomarkers Revenue Growth Rate (2015-2020)
Figure 63. Global Predictive Biomarkers Revenue Growth Rate (2015-2020)
Figure 64. Global Prognostic Biomarkers Revenue Growth Rate (2015-2020)
Figure 65. Global Clinical Biomarkers Revenue Share by Application (2015-2020)
Figure 66. Global Clinical Biomarkers Revenue Share by Application in 2019
Figure 67. Global Clinical Biomarkers Market Share Forecast by Application (2021-2025)
Figure 68. Global Research and Academic Laboratories Revenue Growth Rate (2015-2020)
Figure 69. Global Biopharmaceutical and Biotech Companies Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Clinical Biomarkers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Clinical Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Clinical Biomarkers Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Clinical Biomarkers Revenue Market Forecast (2021-2025)
Figure 76. Europe Clinical Biomarkers Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Clinical Biomarkers Revenue Market Forecast (2021-2025)
Figure 78. South America Clinical Biomarkers Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Clinical Biomarkers Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel